Desmoplastic melanoma with sarcomatoid dedifferentiation.
暂无分享,去创建一个
[1] A. Armstrong,et al. Desmoplastic Melanoma , 2020, Definitions.
[2] G. Salles,et al. PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma. , 2014, The New England journal of medicine.
[3] M. Berger,et al. Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: The role of massively parallel sequencing , 2014, Molecular Oncology.
[4] Cynthia Cohen,et al. SOX10 Expression in Malignant Melanoma, Carcinoma, and Normal Tissues , 2013, Applied immunohistochemistry & molecular morphology : AIMM.
[5] David M. Thomas,et al. Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary , 2013, The Journal of pathology.
[6] S. Dry,et al. SOX10 Expression Distinguishes Desmoplastic Melanoma From Its Histologic Mimics , 2013, The American Journal of dermatopathology.
[7] A. Marghoob,et al. Desmoplastic melanoma: a review. , 2013, Journal of the American Academy of Dermatology.
[8] E. Velazquez,et al. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi , 2013, Modern Pathology.
[9] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[10] Janet Kelso,et al. High‐throughput sequencing of the melanoma genome , 2013, Experimental dermatology.
[11] C. Sander,et al. Genome Sequencing Identifies a Basis for Everolimus Sensitivity , 2012, Science.
[12] A. Hyatt,et al. Collision of atypical fibroxanthoma and acantholytic squamous cell carcinoma in situ. , 2012, The American Journal of dermatopathology.
[13] A. Emley,et al. Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal , 2012, Modern Pathology.
[14] A. Rademaker,et al. Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma. , 2011, The Journal of molecular diagnostics : JMD.
[15] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[16] J. Karamchandani,et al. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar , 2010, Journal of cutaneous pathology.
[17] N. Arsenovic,et al. Trichilemmal cyst with carcinoma in situ within an atypical fibroxanthoma. , 2009, The American Journal of dermatopathology.
[18] H. Kutzner,et al. Metastatic Desmoplastic Malignant Melanoma Associated With Low-Grade Myofibroblastic Sarcoma , 2009, The American Journal of dermatopathology.
[19] N. Polissar,et al. Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis , 2009, Journal of cutaneous pathology.
[20] Luis Chiriboga,et al. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors , 2008, Journal of cutaneous pathology.
[21] M. Lens,et al. Desmoplastic malignant melanoma: a systematic review , 2005, The British journal of dermatology.
[22] K. Busam. Cutaneous Desmoplastic Melanoma , 2005, Advances in anatomic pathology.
[23] J. Davison,et al. Absence of V599E BRAF mutations in desmoplastic melanomas , 2005, Cancer.
[24] D. Coit,et al. Cutaneous Desmoplastic Melanoma: Reappraisal of Morphologic Heterogeneity and Prognostic Factors , 2004, The American journal of surgical pathology.
[25] G. Reifenberger,et al. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas , 2004, International journal of cancer.
[26] L. Ben-Porat,et al. Desmoplastic Melanoma: A Pathologically and Clinically Distinct Form of Cutaneous Melanoma , 2004, Annals of Surgical Oncology.
[27] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[28] R. Gutzmer,et al. Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma , 2000, Human Genetics.
[29] D. Pinkel,et al. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. , 2000, The American journal of pathology.
[30] D. Pinkel,et al. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. , 1999, The Journal of investigative dermatology.
[31] R. Lattes,et al. Desmoplastic malignant melanoma (A rare variant of spindle cell melanoma) , 1972, Cancer.
[32] M. Berger,et al. Basal cell carcinosarcoma with PTCH1 mutations in both epithelial and sarcomatoid primary tumor components and in the sarcomatoid metastasis. , 2014, The American journal of surgical pathology.
[33] Claude-Alain H. Roten,et al. Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..